TenderlineUK
Procurement Intelligence
Official OCDS

Expiring UK Public Contracts: Retender Radar

Explore UK public contracts by expiry date, with buyers, incumbent suppliers and extension options. Estimated end dates are labelled; expiry does not guarantee a new tender.

in Retenders

Syntax:"exact phrase"cleaning OR cateringsoftware -consultancy(cleaning OR catering) AND hospitalgovern*admin+defence

Contracts ending in the all future end dates

Showing 1,801–1,815

SortEnding soonestLargest published valueLargest annual run-rate, exc. VAT
33 · Medical equipments, pharmaceuticalsClear all

2,052 contracts

  1. Estimated end · in 2,456 daysCall-off

    Atropine and Ciprofloxacin 2024-2025

    Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)

    Incumbent: Nationwide Healthcare Solutions LTD · Last contest: 6 bids (3 SME)

    • Pharmaceutical products
    Published value
    £1value of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 20 Jul 2033 · start not published
    Reference
    ocds-h6vhtk-0293b8
  2. Estimated end · in 2,544 days

    Supply, Delivery, Installation, Commissioning, Maintenance and Consumables for Spatial Transcriptomic Equipment.

    Queens University Belfast · Education · Northern Ireland

    Incumbent: 10X Genomics · Last contest: 2 bids (2 SME)

    The Genomics Core Technology Unit (GCTU) at QUB aims to broaden its current single-cell services with new spatial transcriptomic service capacity. The GCTU wishes to purchase single molecule in situ hybridisation spatial equipment with subc…

    • Medical equipments
    Published value
    £2.5m
    Annual run-rate
    —start date not published
    Term
    Estimated end 16 Oct 2033 · start not published
    Reference
    ocds-h6vhtk-0416e6
  3. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Janssen-Cilag Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £6.4mvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  4. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Vifor Pharma UK Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £2.3mvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  5. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Fresenius Kabi Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £1.1mvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  6. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Rosemont Pharmaceuticals Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £912kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  7. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Wockhardt UK Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £667kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  8. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: ACCORD-UK LTD · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £429kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  9. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Chiesi Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £344kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  10. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: MACARTHYS LABORATORIES LTD T/A MARTINDALE PHARMA · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £277kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  11. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Abbvie Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £225kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  12. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Neon Healthcare · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £189kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  13. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Kent Pharmaceuticals Ltd · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £173kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  14. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Bowmed Ibisqus Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £136kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0
  15. Estimated end · in 2,572 daysCall-off

    Generic, Branded Generic & Proprietary Medicinal Products - Group 13

    Procurement and Logistics Service · Northern Ireland

    Incumbent: Flexipharm Austrading Limited · Last contest: 60 bids

    • Pharmaceutical products
    Published value
    £123kvalue of a framework or DPS agreement; may be a ceiling
    Annual run-rate
    —framework or DPS value, not a run-rate
    Term
    Estimated end 13 Nov 2033 · start not published
    Reference
    ocds-h6vhtk-0437e0

When contracts end · Medical equipments, pharmaceuticals
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

An end date does not confirm a new procurement.

1,340 contracts and agreements end within 24 months, 2,052 in total · £2.7bn published GBP values end in the all future end dates, exc. VAT; framework and DPS values, concession values and other ceiling-like amounts are excluded, so this is not a spend forecast.

  1. Next 3 months190
  2. 3–6 months226
  3. 6–12 months361
  4. 12–24 months563

Top sectors, all future end dates
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

An end date does not confirm a new procurement.

Contracts ending in the chosen window, by category.

CPV division of the procedure; a contract with several divisions counts in each. Top 8 of 45 divisions shown.

How to read the radar
  • End date is the contract period end the buyer published on the notice (or on the lot). Where the notice gives only a duration, the end is estimated as the signature date (or, without one, the publication date) plus that duration, and the row says so. Contracts with neither are not on the radar; neither are contracts the buyer cancelled or terminated early.
  • List or panel totals. When one total is repeated on every provider of an approved list or panel, it is shown on the row but never added to the GBP totals or used for a run-rate.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend. Hiding these rows shows contracts without a published option, but does not establish that the buyer will procure them again.
  • Incumbent is the supplier named on the award behind the contract. A panel (several suppliers on one award) is shown as a panel; no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term for a single supplier and a term of six months or more. Values linked to a framework or DPS have no run-rate until we can tell whether they are a ceiling or a contract. The annual sort ranks comparable values excluding VAT first; gross-only values remain visible on their rows. This is not actual annual spend.
  • Counts are exact for the time-horizon and sector filters. A parent framework or DPS counts once; call-offs published by other buyers count separately. Where the parent cannot be identified, agreements stay separate and are marked as linked to a framework or DPS; check the source notice before treating their date or value as a single contract fact. With other filters, a result above 1,000 rows shows as “1,000+”.
  • Source. Official UK procurement notices, reused under the Open Government Licence v3.0; the radar is rebuilt nightly. How we count: methodology.